Loading...
cancelbutton

Feature Stories

Combining local innovation & frugal engineering.

Trivitron Healthcare’s contribution for the detection of Omicron Variants BF.7 and XBB

27 - December - 2022

Trivitron’s R&D conducted an in-silico analysis of mutations of the SARS-CoV-2 virus, ensuring Trivitron’s COVID-19 testing kits can effectively detect the mutated strain variants, Omicron BF.7 and XBB

Trivitron Healthcare has developed and commercialised a wide range of diagnostic products, including VTM, RNA Extraction Kits, COVID-19 Rapid Antigen Test Kits, and COVID-19 RT- PCR test Kits for effective diagnosis of new variants of SARS-CoV-2.

Visit Site

Chat with us